Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Neurophysiological techniques to detect early small-fiber dysfunction in transthyretin amyloid polyneuropathy.

Conceição I, Costa J, Castro J, de Carvalho M.

Muscle Nerve. 2014 Feb;49(2):181-6. doi: 10.1002/mus.23901. Epub 2013 Aug 20.

PMID:
23681916
2.

Neurophysiological markers in familial amyloid polyneuropathy patients: early changes.

Conceição IM, Castro JF, Scotto M, de Carvalho M.

Clin Neurophysiol. 2008 May;119(5):1082-7. doi: 10.1016/j.clinph.2008.01.006. Epub 2008 Mar 4.

PMID:
18308631
3.

Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.

Misu Ki, Hattori N, Nagamatsu M, Ikeda Si, Ando Y, Nakazato M, Takei Yi, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G.

Brain. 1999 Oct;122 ( Pt 10):1951-62.

4.

Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers.

Lefaucheur JP, Ng Wing Tin S, Kerschen P, Damy T, Planté-Bordeneuve V.

J Neurol. 2013 Jun;260(6):1497-503. doi: 10.1007/s00415-012-6816-8. Epub 2013 Jan 11.

PMID:
23306657
5.

The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.

Castro J, Miranda B, Castro I, de Carvalho M, Conceição I.

Clin Neurophysiol. 2016 May;127(5):2222-7. doi: 10.1016/j.clinph.2016.02.013. Epub 2016 Feb 27.

PMID:
27072093
6.

TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients.

Luigetti M, Conte A, Del Grande A, Bisogni G, Madia F, Lo Monaco M, Laurenti L, Obici L, Merlini G, Sabatelli M.

Neurol Sci. 2013 Jul;34(7):1057-63. doi: 10.1007/s10072-012-1105-y. Epub 2012 May 17.

PMID:
22592564
7.

Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.

Koike H, Kawagashira Y, Iijima M, Yamamoto M, Hattori N, Tanaka F, Hirayama M, Ando Y, Ikeda S, Sobue G.

J Neurol. 2008 Oct;255(10):1526-33. doi: 10.1007/s00415-008-0962-z. Epub 2008 Sep 24.

PMID:
18821042
8.

Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.

Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, Sobue G.

Amyloid. 2011 Jun;18(2):53-62. doi: 10.3109/13506129.2011.565524. Epub 2011 Apr 5.

PMID:
21463231
9.

Electromyographic findings in transthyretin (TTR)-related familial amyloid polyneuropathy (FAP).

Montagna P, Marchello L, Plasmati R, Ferlini A, Patrosso MC, Salvi F.

Electroencephalogr Clin Neurophysiol. 1996 Oct;101(5):423-30.

PMID:
8913196
10.
11.

Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).

Planté-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G.

Neurology. 2007 Aug 14;69(7):693-8.

PMID:
17698792
12.

Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials.

Suanprasert N, Berk JL, Benson MD, Dyck PJ, Klein CJ, Gollob JA, Bettencourt BR, Karsten V, Dyck PJ.

J Neurol Sci. 2014 Sep 15;344(1-2):121-8. doi: 10.1016/j.jns.2014.06.041. Epub 2014 Jun 27.

PMID:
25012480
13.

Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.

Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, Hattori N, Mukai E, Ando Y, Ikeda S, Sobue G.

Neurology. 2004 Jul 13;63(1):129-38.

PMID:
15249622
14.

Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.

Dohrn MF, Röcken C, De Bleecker JL, Martin JJ, Vorgerd M, Van den Bergh PY, Ferbert A, Hinderhofer K, Schröder JM, Weis J, Schulz JB, Claeys KG.

J Neurol. 2013 Dec;260(12):3093-108. doi: 10.1007/s00415-013-7124-7. Epub 2013 Oct 8.

PMID:
24101130
15.

Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.

Leibou L, Frand J, Sadeh M, Lossos A, Kremer E, Livneh A, Yarnitsky D, Herman O, Dabby R.

Isr Med Assoc J. 2012 Nov;14(11):662-5.

16.

In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.

Kollmer J, Hund E, Hornung B, Hegenbart U, Schönland SO, Kimmich C, Kristen AV, Purrucker J, Röcken C, Heiland S, Bendszus M, Pham M.

Brain. 2015 Mar;138(Pt 3):549-62. doi: 10.1093/brain/awu344. Epub 2014 Dec 18.

17.

Electrophysiological features of familial amyloid polyneuropathy in endemic area.

Kodaira M, Morita H, Shimojima Y, Ikeda S.

Amyloid. 2011 Mar;18(1):10-8. doi: 10.3109/13506129.2010.548424. Epub 2011 Jan 25.

PMID:
21261557
18.

[Familial amyloidotic polyneuropathy type I].

Guevara C, Barrientos N, Flores A, Idiáquez J.

Rev Med Chil. 2003 Oct;131(10):1179-82. Spanish.

PMID:
14692309
19.

Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.

Rudolph T, Kurz MW, Farbu E.

Clin Med Res. 2008 Sep;6(2):80-2. doi: 10.3121/cmr.2008.794. Epub 2008 Jul 7.

20.

Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.

Sousa MM, Ferrão J, Fernandes R, Guimarães A, Geraldes JB, Perdigoto R, Tomé L, Mota O, Negrão L, Furtado AL, Saraiva MJ.

Lab Invest. 2004 Jul;84(7):865-73.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk